Keywords: hmr, arava, moves, closer, approval, hoechst, marion
HMR's Arava Moves Closer To US Approval
Article | 12 August 1998
Hoechst Marion Roussel's new treatment for active rheumatoid arthritisin adults, Arava (leflunomide), has received a unanimous recommendation for approval from ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
